box plots and scatter plots Search Results


boxplots and scatter plots figures  (GraphPad Software Inc)
90
GraphPad Software Inc boxplots and scatter plots figures
Dysregulated lncRNAs in glioblastoma. (a) Venn diagram showing commonly dysregulated lncRNAs by 1.0-fold or greater (p <0.05) in both datasets GSE50161 and GSE4290. (b) (A-J) <t>Boxplots</t> of expression levels of selected up- and down-regulated lncRNAs in glioblastoma compared with normal or epilepsy non-tumor brain tissues. P-values were calculated using on-way ANOVA where: ∗∗ p <0.01, ∗∗∗ p <0.001, ∗∗∗∗ p <0.0001, G1 vs N and G2 vs E.
Boxplots And Scatter Plots Figures, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/boxplots and scatter plots figures/product/GraphPad Software Inc
Average 90 stars, based on 1 article reviews
boxplots and scatter plots figures - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
scatter plot  (Clinical and Laboratory Standards Institute)
90
Clinical and Laboratory Standards Institute scatter plot
Dysregulated lncRNAs in glioblastoma. (a) Venn diagram showing commonly dysregulated lncRNAs by 1.0-fold or greater (p <0.05) in both datasets GSE50161 and GSE4290. (b) (A-J) <t>Boxplots</t> of expression levels of selected up- and down-regulated lncRNAs in glioblastoma compared with normal or epilepsy non-tumor brain tissues. P-values were calculated using on-way ANOVA where: ∗∗ p <0.01, ∗∗∗ p <0.001, ∗∗∗∗ p <0.0001, G1 vs N and G2 vs E.
Scatter Plot, supplied by Clinical and Laboratory Standards Institute, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/scatter plot/product/Clinical and Laboratory Standards Institute
Average 90 stars, based on 1 article reviews
scatter plot - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
scatter plots and histograms  (GraphPad Software Inc)
90
GraphPad Software Inc scatter plots and histograms
Dysregulated lncRNAs in glioblastoma. (a) Venn diagram showing commonly dysregulated lncRNAs by 1.0-fold or greater (p <0.05) in both datasets GSE50161 and GSE4290. (b) (A-J) <t>Boxplots</t> of expression levels of selected up- and down-regulated lncRNAs in glioblastoma compared with normal or epilepsy non-tumor brain tissues. P-values were calculated using on-way ANOVA where: ∗∗ p <0.01, ∗∗∗ p <0.001, ∗∗∗∗ p <0.0001, G1 vs N and G2 vs E.
Scatter Plots And Histograms, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/scatter plots and histograms/product/GraphPad Software Inc
Average 90 stars, based on 1 article reviews
scatter plots and histograms - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
scatter plot and density plot  (OriginLab corp)
90
OriginLab corp scatter plot and density plot
Dysregulated lncRNAs in glioblastoma. (a) Venn diagram showing commonly dysregulated lncRNAs by 1.0-fold or greater (p <0.05) in both datasets GSE50161 and GSE4290. (b) (A-J) <t>Boxplots</t> of expression levels of selected up- and down-regulated lncRNAs in glioblastoma compared with normal or epilepsy non-tumor brain tissues. P-values were calculated using on-way ANOVA where: ∗∗ p <0.01, ∗∗∗ p <0.001, ∗∗∗∗ p <0.0001, G1 vs N and G2 vs E.
Scatter Plot And Density Plot, supplied by OriginLab corp, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/scatter plot and density plot/product/OriginLab corp
Average 90 stars, based on 1 article reviews
scatter plot and density plot - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
bar diagrams and scatter plots with bar diagrams  (GraphPad Software Inc)
90
GraphPad Software Inc bar diagrams and scatter plots with bar diagrams
Dysregulated lncRNAs in glioblastoma. (a) Venn diagram showing commonly dysregulated lncRNAs by 1.0-fold or greater (p <0.05) in both datasets GSE50161 and GSE4290. (b) (A-J) <t>Boxplots</t> of expression levels of selected up- and down-regulated lncRNAs in glioblastoma compared with normal or epilepsy non-tumor brain tissues. P-values were calculated using on-way ANOVA where: ∗∗ p <0.01, ∗∗∗ p <0.001, ∗∗∗∗ p <0.0001, G1 vs N and G2 vs E.
Bar Diagrams And Scatter Plots With Bar Diagrams, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/bar diagrams and scatter plots with bar diagrams/product/GraphPad Software Inc
Average 90 stars, based on 1 article reviews
bar diagrams and scatter plots with bar diagrams - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
bar charts or scatter dot plots  (GraphPad Software Inc)
90
GraphPad Software Inc bar charts or scatter dot plots
Dysregulated lncRNAs in glioblastoma. (a) Venn diagram showing commonly dysregulated lncRNAs by 1.0-fold or greater (p <0.05) in both datasets GSE50161 and GSE4290. (b) (A-J) <t>Boxplots</t> of expression levels of selected up- and down-regulated lncRNAs in glioblastoma compared with normal or epilepsy non-tumor brain tissues. P-values were calculated using on-way ANOVA where: ∗∗ p <0.01, ∗∗∗ p <0.001, ∗∗∗∗ p <0.0001, G1 vs N and G2 vs E.
Bar Charts Or Scatter Dot Plots, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/bar charts or scatter dot plots/product/GraphPad Software Inc
Average 90 stars, based on 1 article reviews
bar charts or scatter dot plots - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
scatter plot of mx1 and mx2 gene expression levels  (RStudio)
90
RStudio scatter plot of mx1 and mx2 gene expression levels
Gene expression analysis based on SARS-CoV-2 positivity and age Dot plot for <t>MX1</t> expression (i) and statistical output from RStudio (ii) for: (A) SARS-CoV-2 positive vs . negative patients (P-values correspond to Wilcoxon rank-sum test); (B) SARS-CoV-2 positive vs . negative patients categorized by age groups (P-values correspond to decreasing Jonckheere-Terpstra trend test. Alternative hypothesis: Median i > Median j > … > Median n , indicating that gene expression is significantly lower in SARS-CoV-2 patients when age is increased. Left panel: SARS-CoV-2 negative; right panel: SARS-CoV-2 positive). A.i and B.i were adapted with permission from <xref ref-type=Bizzotto et al., 2020 . " width="250" height="auto" />
Scatter Plot Of Mx1 And Mx2 Gene Expression Levels, supplied by RStudio, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/scatter plot of mx1 and mx2 gene expression levels/product/RStudio
Average 90 stars, based on 1 article reviews
scatter plot of mx1 and mx2 gene expression levels - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
heatmaps and scatter plots  (GraphPad Software Inc)
90
GraphPad Software Inc heatmaps and scatter plots
Gene expression analysis based on SARS-CoV-2 positivity and age Dot plot for <t>MX1</t> expression (i) and statistical output from RStudio (ii) for: (A) SARS-CoV-2 positive vs . negative patients (P-values correspond to Wilcoxon rank-sum test); (B) SARS-CoV-2 positive vs . negative patients categorized by age groups (P-values correspond to decreasing Jonckheere-Terpstra trend test. Alternative hypothesis: Median i > Median j > … > Median n , indicating that gene expression is significantly lower in SARS-CoV-2 patients when age is increased. Left panel: SARS-CoV-2 negative; right panel: SARS-CoV-2 positive). A.i and B.i were adapted with permission from <xref ref-type=Bizzotto et al., 2020 . " width="250" height="auto" />
Heatmaps And Scatter Plots, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/heatmaps and scatter plots/product/GraphPad Software Inc
Average 90 stars, based on 1 article reviews
heatmaps and scatter plots - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
heatmap (figure 1c) and scatter plot (figure 2c)  (Partek)
90
Partek heatmap (figure 1c) and scatter plot (figure 2c)
Gene expression analysis based on SARS-CoV-2 positivity and age Dot plot for <t>MX1</t> expression (i) and statistical output from RStudio (ii) for: (A) SARS-CoV-2 positive vs . negative patients (P-values correspond to Wilcoxon rank-sum test); (B) SARS-CoV-2 positive vs . negative patients categorized by age groups (P-values correspond to decreasing Jonckheere-Terpstra trend test. Alternative hypothesis: Median i > Median j > … > Median n , indicating that gene expression is significantly lower in SARS-CoV-2 patients when age is increased. Left panel: SARS-CoV-2 negative; right panel: SARS-CoV-2 positive). A.i and B.i were adapted with permission from <xref ref-type=Bizzotto et al., 2020 . " width="250" height="auto" />
Heatmap (Figure 1c) And Scatter Plot (Figure 2c), supplied by Partek, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/heatmap (figure 1c) and scatter plot (figure 2c)/product/Partek
Average 90 stars, based on 1 article reviews
heatmap (figure 1c) and scatter plot (figure 2c) - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
vertical scatter plot of map4k mrna expression and survival curves for map4k family  (GraphPad Software Inc)
90
GraphPad Software Inc vertical scatter plot of map4k mrna expression and survival curves for map4k family
Metabolic gEne RApid Visualizer boxplots for <t>MAP4K</t> gene expression in normal hematopoietic and lymphoid tissue and primary AML tissue: (A) MAP4K1; (B) MAP4K2; (C) MAP4K3; (D) MAP4K4; (E) MAP4K5; and (F) MINK1. AML indicates acute myeloid leukemia; MAP4K, MAP kinase kinase kinase kinase.
Vertical Scatter Plot Of Map4k Mrna Expression And Survival Curves For Map4k Family, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/vertical scatter plot of map4k mrna expression and survival curves for map4k family/product/GraphPad Software Inc
Average 90 stars, based on 1 article reviews
vertical scatter plot of map4k mrna expression and survival curves for map4k family - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
figures for t-sne, scatter plot and trajectory analysis  (Partek)
90
Partek figures for t-sne, scatter plot and trajectory analysis
Metabolic gEne RApid Visualizer boxplots for <t>MAP4K</t> gene expression in normal hematopoietic and lymphoid tissue and primary AML tissue: (A) MAP4K1; (B) MAP4K2; (C) MAP4K3; (D) MAP4K4; (E) MAP4K5; and (F) MINK1. AML indicates acute myeloid leukemia; MAP4K, MAP kinase kinase kinase kinase.
Figures For T Sne, Scatter Plot And Trajectory Analysis, supplied by Partek, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/figures for t-sne, scatter plot and trajectory analysis/product/Partek
Average 90 stars, based on 1 article reviews
figures for t-sne, scatter plot and trajectory analysis - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
scatter plot of the size of the lumen and ventral and dorsal regions  (GraphPad Software Inc)
90
GraphPad Software Inc scatter plot of the size of the lumen and ventral and dorsal regions
Metabolic gEne RApid Visualizer boxplots for <t>MAP4K</t> gene expression in normal hematopoietic and lymphoid tissue and primary AML tissue: (A) MAP4K1; (B) MAP4K2; (C) MAP4K3; (D) MAP4K4; (E) MAP4K5; and (F) MINK1. AML indicates acute myeloid leukemia; MAP4K, MAP kinase kinase kinase kinase.
Scatter Plot Of The Size Of The Lumen And Ventral And Dorsal Regions, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/scatter plot of the size of the lumen and ventral and dorsal regions/product/GraphPad Software Inc
Average 90 stars, based on 1 article reviews
scatter plot of the size of the lumen and ventral and dorsal regions - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

Image Search Results


Dysregulated lncRNAs in glioblastoma. (a) Venn diagram showing commonly dysregulated lncRNAs by 1.0-fold or greater (p <0.05) in both datasets GSE50161 and GSE4290. (b) (A-J) Boxplots of expression levels of selected up- and down-regulated lncRNAs in glioblastoma compared with normal or epilepsy non-tumor brain tissues. P-values were calculated using on-way ANOVA where: ∗∗ p <0.01, ∗∗∗ p <0.001, ∗∗∗∗ p <0.0001, G1 vs N and G2 vs E.

Journal: Oxidative Medicine and Cellular Longevity

Article Title: Therapy-resistant and -sensitive lncRNAs, SNHG1 and UBL7-AS1 promote glioblastoma cell proliferation

doi: 10.1155/2022/2623599

Figure Lengend Snippet: Dysregulated lncRNAs in glioblastoma. (a) Venn diagram showing commonly dysregulated lncRNAs by 1.0-fold or greater (p <0.05) in both datasets GSE50161 and GSE4290. (b) (A-J) Boxplots of expression levels of selected up- and down-regulated lncRNAs in glioblastoma compared with normal or epilepsy non-tumor brain tissues. P-values were calculated using on-way ANOVA where: ∗∗ p <0.01, ∗∗∗ p <0.001, ∗∗∗∗ p <0.0001, G1 vs N and G2 vs E.

Article Snippet: Boxplots and scatter plots figures were generated using GraphPad Prism version 6.01 for Windows (GraphPad Software).

Techniques: Expressing

Gene expression analysis based on SARS-CoV-2 positivity and age Dot plot for MX1 expression (i) and statistical output from RStudio (ii) for: (A) SARS-CoV-2 positive vs . negative patients (P-values correspond to Wilcoxon rank-sum test); (B) SARS-CoV-2 positive vs . negative patients categorized by age groups (P-values correspond to decreasing Jonckheere-Terpstra trend test. Alternative hypothesis: Median i > Median j > … > Median n , indicating that gene expression is significantly lower in SARS-CoV-2 patients when age is increased. Left panel: SARS-CoV-2 negative; right panel: SARS-CoV-2 positive). A.i and B.i were adapted with permission from <xref ref-type=Bizzotto et al., 2020 . " width="100%" height="100%">

Journal: STAR Protocols

Article Title: Analysis workflow of publicly available RNA-sequencing datasets

doi: 10.1016/j.xpro.2021.100478

Figure Lengend Snippet: Gene expression analysis based on SARS-CoV-2 positivity and age Dot plot for MX1 expression (i) and statistical output from RStudio (ii) for: (A) SARS-CoV-2 positive vs . negative patients (P-values correspond to Wilcoxon rank-sum test); (B) SARS-CoV-2 positive vs . negative patients categorized by age groups (P-values correspond to decreasing Jonckheere-Terpstra trend test. Alternative hypothesis: Median i > Median j > … > Median n , indicating that gene expression is significantly lower in SARS-CoV-2 patients when age is increased. Left panel: SARS-CoV-2 negative; right panel: SARS-CoV-2 positive). A.i and B.i were adapted with permission from Bizzotto et al., 2020 .

Article Snippet: Statistical significance: ∗ p < 0.05; ∗∗ p < 0.01; ∗∗∗ p < 0.001. (B) Scatter plot of MX1 and MX2 gene expression levels, color-coded by viral load (i) and Spearman correlation output in RStudio (ii).

Techniques: Gene Expression, Expressing

Correlation analysis (A) Pairwise Spearman correlation matrix analysis between all genes of interest ( MX1 , MX2 , ACE2 and TMPRSS2 ), considering different infection status (all patients together (Corr.), SARS-CoV-2 negative (HEALTHY), or SARS-CoV-2 positive patients (COVID19)). Alternative hypothesis: rho (ρ) ≠ 0, which indicates that there is a lineal correlation between the variables under study. Statistical significance: ∗ p < 0.05; ∗∗ p < 0.01; ∗∗∗ p < 0.001. (B) Scatter plot of MX1 and MX2 gene expression levels, color-coded by viral load (i) and Spearman correlation output in RStudio (ii). A and 3B.i were adapted with permission from <xref ref-type=Bizzotto et al., 2020 . " width="100%" height="100%">

Journal: STAR Protocols

Article Title: Analysis workflow of publicly available RNA-sequencing datasets

doi: 10.1016/j.xpro.2021.100478

Figure Lengend Snippet: Correlation analysis (A) Pairwise Spearman correlation matrix analysis between all genes of interest ( MX1 , MX2 , ACE2 and TMPRSS2 ), considering different infection status (all patients together (Corr.), SARS-CoV-2 negative (HEALTHY), or SARS-CoV-2 positive patients (COVID19)). Alternative hypothesis: rho (ρ) ≠ 0, which indicates that there is a lineal correlation between the variables under study. Statistical significance: ∗ p < 0.05; ∗∗ p < 0.01; ∗∗∗ p < 0.001. (B) Scatter plot of MX1 and MX2 gene expression levels, color-coded by viral load (i) and Spearman correlation output in RStudio (ii). A and 3B.i were adapted with permission from Bizzotto et al., 2020 .

Article Snippet: Statistical significance: ∗ p < 0.05; ∗∗ p < 0.01; ∗∗∗ p < 0.001. (B) Scatter plot of MX1 and MX2 gene expression levels, color-coded by viral load (i) and Spearman correlation output in RStudio (ii).

Techniques: Infection, Gene Expression

Patient segregation based on gene expression (A) Principal component analysis (PCA) output in RStudio, showing the first two principal components explaining most part of the variance among samples. (B) PCA biplot of gene expression data showing a rough segregation of SARS-CoV-2 positive and negative samples. (C) 3D scatter plot for the expression of three genes of interest ( BSG , MX1 and ACE2 ). Samples are colored by SARS-CoV-2 status (positive or negative). Ellipsoids represent the 95% confidence interval. B and 4C were adapted with permission from <xref ref-type=Bizzotto et al., 2020 . " width="100%" height="100%">

Journal: STAR Protocols

Article Title: Analysis workflow of publicly available RNA-sequencing datasets

doi: 10.1016/j.xpro.2021.100478

Figure Lengend Snippet: Patient segregation based on gene expression (A) Principal component analysis (PCA) output in RStudio, showing the first two principal components explaining most part of the variance among samples. (B) PCA biplot of gene expression data showing a rough segregation of SARS-CoV-2 positive and negative samples. (C) 3D scatter plot for the expression of three genes of interest ( BSG , MX1 and ACE2 ). Samples are colored by SARS-CoV-2 status (positive or negative). Ellipsoids represent the 95% confidence interval. B and 4C were adapted with permission from Bizzotto et al., 2020 .

Article Snippet: Statistical significance: ∗ p < 0.05; ∗∗ p < 0.01; ∗∗∗ p < 0.001. (B) Scatter plot of MX1 and MX2 gene expression levels, color-coded by viral load (i) and Spearman correlation output in RStudio (ii).

Techniques: Gene Expression, Expressing

Metabolic gEne RApid Visualizer boxplots for MAP4K gene expression in normal hematopoietic and lymphoid tissue and primary AML tissue: (A) MAP4K1; (B) MAP4K2; (C) MAP4K3; (D) MAP4K4; (E) MAP4K5; and (F) MINK1. AML indicates acute myeloid leukemia; MAP4K, MAP kinase kinase kinase kinase.

Journal: Technology in Cancer Research & Treatment

Article Title: Prognostic Value of mRNA Expression of MAP4K Family in Acute Myeloid Leukemia

doi: 10.1177/1533033819873927

Figure Lengend Snippet: Metabolic gEne RApid Visualizer boxplots for MAP4K gene expression in normal hematopoietic and lymphoid tissue and primary AML tissue: (A) MAP4K1; (B) MAP4K2; (C) MAP4K3; (D) MAP4K4; (E) MAP4K5; and (F) MINK1. AML indicates acute myeloid leukemia; MAP4K, MAP kinase kinase kinase kinase.

Article Snippet: Vertical scatter plot of MAP4K mRNA expression and survival curves for MAP4K family were generated in GraphPad Prism v.7.0 (La Jolla, California).

Techniques: Gene Expression

Transcript expression of MAP4K genes in multiple normal tissues and AML. The expression of MAP4K genes in AML is highlighted in red. (A) MAP4K1; (B) MAP4K3; (C) MAP4K4; (D) MAP4K5. AML indicates acute myeloid leukemia; MAP4K, MAP kinase kinase kinase kinase.

Journal: Technology in Cancer Research & Treatment

Article Title: Prognostic Value of mRNA Expression of MAP4K Family in Acute Myeloid Leukemia

doi: 10.1177/1533033819873927

Figure Lengend Snippet: Transcript expression of MAP4K genes in multiple normal tissues and AML. The expression of MAP4K genes in AML is highlighted in red. (A) MAP4K1; (B) MAP4K3; (C) MAP4K4; (D) MAP4K5. AML indicates acute myeloid leukemia; MAP4K, MAP kinase kinase kinase kinase.

Article Snippet: Vertical scatter plot of MAP4K mRNA expression and survival curves for MAP4K family were generated in GraphPad Prism v.7.0 (La Jolla, California).

Techniques: Expressing

A, Analysis of enriched GO terms and KEGG pathways for MAP4K genes by using Database for Annotation, Visualization, and Integrated Discovery. B, Gene interaction networks according to selected gene expression levels in GeneMANIA. C, Pearson correlation coefficients for MAP4K1, MAP4K2, MAP4K3, MAP4K4, MAP4K5, and MINK1 gene expression levels. ** P < .05. GO indicates Gene Ontology; KEGG, Kyoto Encyclopedia of Genes and Genomes; MAP4K, MAP kinase kinase kinase kinase.

Journal: Technology in Cancer Research & Treatment

Article Title: Prognostic Value of mRNA Expression of MAP4K Family in Acute Myeloid Leukemia

doi: 10.1177/1533033819873927

Figure Lengend Snippet: A, Analysis of enriched GO terms and KEGG pathways for MAP4K genes by using Database for Annotation, Visualization, and Integrated Discovery. B, Gene interaction networks according to selected gene expression levels in GeneMANIA. C, Pearson correlation coefficients for MAP4K1, MAP4K2, MAP4K3, MAP4K4, MAP4K5, and MINK1 gene expression levels. ** P < .05. GO indicates Gene Ontology; KEGG, Kyoto Encyclopedia of Genes and Genomes; MAP4K, MAP kinase kinase kinase kinase.

Article Snippet: Vertical scatter plot of MAP4K mRNA expression and survival curves for MAP4K family were generated in GraphPad Prism v.7.0 (La Jolla, California).

Techniques: Gene Expression

Prognostic value of MAP4K genes expression. A-F, Kaplan-Meier survival curves for all patients with AML according to MAP4K1 (A), MAP4K2 (B), MAP4K3 (C), MAP4K4 (D), MAP4K5 (E), and MINK1 (F) expression. AML indicates acute myeloid leukemia; MAP4K, MAP kinase kinase kinase kinase.

Journal: Technology in Cancer Research & Treatment

Article Title: Prognostic Value of mRNA Expression of MAP4K Family in Acute Myeloid Leukemia

doi: 10.1177/1533033819873927

Figure Lengend Snippet: Prognostic value of MAP4K genes expression. A-F, Kaplan-Meier survival curves for all patients with AML according to MAP4K1 (A), MAP4K2 (B), MAP4K3 (C), MAP4K4 (D), MAP4K5 (E), and MINK1 (F) expression. AML indicates acute myeloid leukemia; MAP4K, MAP kinase kinase kinase kinase.

Article Snippet: Vertical scatter plot of MAP4K mRNA expression and survival curves for MAP4K family were generated in GraphPad Prism v.7.0 (La Jolla, California).

Techniques: Expressing

Prognostic Survival Analysis for High or Low Expression of MAP4K Family Genes.

Journal: Technology in Cancer Research & Treatment

Article Title: Prognostic Value of mRNA Expression of MAP4K Family in Acute Myeloid Leukemia

doi: 10.1177/1533033819873927

Figure Lengend Snippet: Prognostic Survival Analysis for High or Low Expression of MAP4K Family Genes.

Article Snippet: Vertical scatter plot of MAP4K mRNA expression and survival curves for MAP4K family were generated in GraphPad Prism v.7.0 (La Jolla, California).

Techniques: Expressing

Joint effect analysis for MAP4K genes expression with stratified OS according to 2 selected MAP4K genes among MAP4K1, MAP4K3, MAP4K4, and MAP4K5. (A) MAP4K1 and MAP4K3, (B) MAP4K1 and MAP4K4, (C) MAP4K1 and MAP4K5, (D) MAP4K3 and MAP4K4, (E) MAP4K3 and MAP4K5, and (F) MAP4K4 and MAP4K5. Group A, low MAP4K1 + high MAP4K3; group C, high MAP4K1 + low MAP4K3; group D, low MAP4K1 + high MAP4K4; group F, high MAP4K1 + low MAP4K4; group G, low MAP4K1 + high MAP4K5; group I, high MAP4K1 + low MAP4K5; group J, high MAP4K3 + high MAP4K4; group L, low MAP4K3 + low MAP4K4; group M, high MAP4K3 + high MAP4K5; group O, low MAP4K3 + low MAP4K5; group P, high MAP4K4 + high MAP4K5; group R, low MAP4K4 + low MAP4K5; groups B, E, H, K, N, and Q correspond to other combinations of genes as detailed in . MAP4K indicates MAP kinase kinase kinase kinase; OS, overall survival.

Journal: Technology in Cancer Research & Treatment

Article Title: Prognostic Value of mRNA Expression of MAP4K Family in Acute Myeloid Leukemia

doi: 10.1177/1533033819873927

Figure Lengend Snippet: Joint effect analysis for MAP4K genes expression with stratified OS according to 2 selected MAP4K genes among MAP4K1, MAP4K3, MAP4K4, and MAP4K5. (A) MAP4K1 and MAP4K3, (B) MAP4K1 and MAP4K4, (C) MAP4K1 and MAP4K5, (D) MAP4K3 and MAP4K4, (E) MAP4K3 and MAP4K5, and (F) MAP4K4 and MAP4K5. Group A, low MAP4K1 + high MAP4K3; group C, high MAP4K1 + low MAP4K3; group D, low MAP4K1 + high MAP4K4; group F, high MAP4K1 + low MAP4K4; group G, low MAP4K1 + high MAP4K5; group I, high MAP4K1 + low MAP4K5; group J, high MAP4K3 + high MAP4K4; group L, low MAP4K3 + low MAP4K4; group M, high MAP4K3 + high MAP4K5; group O, low MAP4K3 + low MAP4K5; group P, high MAP4K4 + high MAP4K5; group R, low MAP4K4 + low MAP4K5; groups B, E, H, K, N, and Q correspond to other combinations of genes as detailed in . MAP4K indicates MAP kinase kinase kinase kinase; OS, overall survival.

Article Snippet: Vertical scatter plot of MAP4K mRNA expression and survival curves for MAP4K family were generated in GraphPad Prism v.7.0 (La Jolla, California).

Techniques: Expressing

Joint effect analysis for MAP4K genes expression with stratified OS according to 3 or 4 selected MAP4K genes among MAP4K1, MAP4K3, MAP4K4, and MAP4K5. (A) MAP4K1, MAP4K3, and MAP4K4; (B) MAP4K1, MAP4K3, and MAP4K5; (C) MAP4K1, MAP4K4, and MAP4K5; (D) MAP4K3, MAP4K4, and MAP4K5; (E) MAP4K1, MAP4K3, MAP4K4, and MAP4K5. Group i, Low MAP4K1 + high MAP4K3 + high MAP4K4; group iii, High MAP4K1 + low MAP4K3 + low MAP4K4; group iv, Low MAP4K1 + high MAP4K3 + high MAP4K5; group vi, High MAP4K1 + low MAP4K3 + low MAP4K5; group vii, Low MAP4K1 + high MAP4K4 + high MAP4K5; group ix, High MAP4K1 + low MAP4K4 + low MAP4K5; group x, High MAP4K3 + high MAP4K4 + high MAP4K5; group xii, Low MAP4K3 + low MAP4K4 + low MAP4K5. Group ii, v, viii, and xi correspond to other combinations of genes as detailed in . Group 1, low MAP4K1 + high MAP4K3 + high MAP4K4 + high MAP4K5; group 3, High MAP4K1 + low MAP4K3 + low MAP4K4 + low MAP4K5. 2 correspond to other combinations of genes as detailed in . MAP4K indicates MAP kinase kinase kinase kinase; OS, overall survival.

Journal: Technology in Cancer Research & Treatment

Article Title: Prognostic Value of mRNA Expression of MAP4K Family in Acute Myeloid Leukemia

doi: 10.1177/1533033819873927

Figure Lengend Snippet: Joint effect analysis for MAP4K genes expression with stratified OS according to 3 or 4 selected MAP4K genes among MAP4K1, MAP4K3, MAP4K4, and MAP4K5. (A) MAP4K1, MAP4K3, and MAP4K4; (B) MAP4K1, MAP4K3, and MAP4K5; (C) MAP4K1, MAP4K4, and MAP4K5; (D) MAP4K3, MAP4K4, and MAP4K5; (E) MAP4K1, MAP4K3, MAP4K4, and MAP4K5. Group i, Low MAP4K1 + high MAP4K3 + high MAP4K4; group iii, High MAP4K1 + low MAP4K3 + low MAP4K4; group iv, Low MAP4K1 + high MAP4K3 + high MAP4K5; group vi, High MAP4K1 + low MAP4K3 + low MAP4K5; group vii, Low MAP4K1 + high MAP4K4 + high MAP4K5; group ix, High MAP4K1 + low MAP4K4 + low MAP4K5; group x, High MAP4K3 + high MAP4K4 + high MAP4K5; group xii, Low MAP4K3 + low MAP4K4 + low MAP4K5. Group ii, v, viii, and xi correspond to other combinations of genes as detailed in . Group 1, low MAP4K1 + high MAP4K3 + high MAP4K4 + high MAP4K5; group 3, High MAP4K1 + low MAP4K3 + low MAP4K4 + low MAP4K5. 2 correspond to other combinations of genes as detailed in . MAP4K indicates MAP kinase kinase kinase kinase; OS, overall survival.

Article Snippet: Vertical scatter plot of MAP4K mRNA expression and survival curves for MAP4K family were generated in GraphPad Prism v.7.0 (La Jolla, California).

Techniques: Expressing